Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
autoimmune disease
Biotech
AbbVie inks $2.1B Capstan buyout to enter in vivo CAR-T market
AbbVie is making a full strength play for the in vivo CAR-T market, snapping up Capstan to add an early-phase autoimmune candidate to its pipeline.
Nick Paul Taylor
Jun 30, 2025 9:45am
Arialys presents promising data for IgG1 antibody treatment
Jun 20, 2025 5:02am
Big Pharma-backed GlycoEra raises $130M for protein degraders
May 27, 2025 7:00am
Octagon shuts down after R&D challenges put it behind the 8 ball
Apr 29, 2025 7:40am
Genentech builds autoimmune Repertoire with $765M deal
Apr 23, 2025 7:00am
Immunovant narrows R&D focus as Roivant execs join C-suite
Apr 21, 2025 10:00am
